Amphotericin B Serum Concentrations During Therapy 1
AUTOR(ES)
Fields, Branch T.
RESUMO
Therapeutic outcome of patients being treated for systemic mycoses with amphotericin B is possibly related to the serum concentrations of this drug that are produced in these patients. Because current data are conflicting, the magnitude of these concentrations was restudied by using a bioassay which gave precise and accurate results. The highest of 155 serum concentrations was 2.01 μg/ml. Mean concentrations were 1.21, 0.62, and 0.32 μg/ml, at 1, 18, and 42 hr, respectively, after intravenous infusion of amphotericin B. This drug was detected in serum 7 weeks after completion of treatment, but it could not be detected 13 weeks after treatment. Drug levels did not appreciably decrease in serum stored for 8 to 9 months at − 10 C. Unequal serum content in assay tubes and measurement of assay turbidity by visual inspection may explain previously reported amphotericin B levels of 3.0 to 12.5 μg/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=376832Documentos Relacionados
- Effect of Rapid Intravenous Infusion on Serum Concentrations of Amphotericin B 1
- Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion.
- SERUM PRECIPITABLE IODINE CONCENTRATIONS DURING PREGNANCY 1
- Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate.
- Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease.
